EMAIL THIS PAGE TO A FRIEND

Drug research

Diclofenac-Choline Antioxidant Activity Investigated by means of Luminol Amplified Chemiluminescence of Human Neutrophil Bursts and Electron Paramagnetic Resonance Spectroscopy.


PMID 24918344

Abstract

A new diclofenac salt called diclofenac-choline (DC) has recently been proposed for the symptomatic treatment of oropharyngeal inflammatory processes and pain because its greater water solubility allows the use of high concentrations, which are useful when the contact time between the drug and the oropharyngeal mucosa is brief, as in the case of mouthwashes or spray formulations. The antioxidant activity of DC has not yet been investigated, and so the aim was to use luminol-amplified-chemiluminescence (LACL) to verify whether various concentrations of DC (1.48, 0.74 and 0.37 mg/mL for incubation times of 2, 4 and 8 min) interfere with oxygen and nitrogen radicals during the course of human neutrophils respiratory bursts; electron paramagnetic resonance (EPR) spectroscopy was used to investigate its direct antiradical (scavenger) activity. The EPR findings showed that DC has concentration-dependent scavenging activity against the ABTS, the DPPH, and the hydroxyl radicals, but no activity on superoxide anion, as has been previously reported in the case of other NSAIDs. LACL revealed an inhibitory effect that was statistically significant after only 2 min of incubation, and similar after 4 and 8 min. The effects on the peroxynitrite radical paralleled those observed in the previous test. High concentrations and short incubation times showed that there is no interference on PMN viability, and so the inhibitory findings must be attributed to the effect of the drug. The anti-inflammatory effects of DC cannot be attributed solely to the inhibition of prostaglandin synthesis, but its effects on free radicals and neutrophil bursts suggest that they may contribute to its final therapeutic effect.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D5766
5,5-Dimethyl-1-pyrroline N-oxide, ≥97%
C6H11NO
194581
5,5-Dimethyl-1-pyrroline N-oxide, 97%
C6H11NO
D6518
Diethylenetriaminepentaacetic acid, ≥99% (titration)
C14H23N3O10
D1133
Diethylenetriaminepentaacetic acid, ≥98% (titration)
C14H23N3O10
2107
E-Toxate Water, endotoxin, free
H2O
W381918
L-Arginine, 99%, FCC, FG
C6H14N4O2
A5006
L-Arginine, reagent grade, ≥98%
C6H14N4O2
A8094
L-Arginine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
C6H14N4O2
A4474
L-Arginine, PharmaGrade, Ajinomoto, EP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
C6H14N4O2
11009
L-Arginine, BioUltra, ≥99.5% (NT)
C6H14N4O2
672874
Lead magnesium niobate, ≥99% trace metals basis
MgNb2Pb3O9
123072
Luminol, 97%
C8H7N3O2
A8511
Luminol, ≥97% (HPLC)
C8H7N3O2
P5592
Potassium peroxodisulfate, BioXtra, ≥99.0%
K2O8S2
379824
Potassium persulfate, 99.99% trace metals basis
K2O8S2
W3500
Water, sterile-filtered, BioReagent, suitable for cell culture
H2O
W3513
Water, BioPerformance Certified
H2O
95289
Water, for cell biology, free of endotoxins, ultrafiltered and autoclaved
H2O
95284
Water, for molecular biology, DEPC-treated and sterile filtered
H2O
697125
Water, packaged for use in deposition systems
H2O
195294
Water, deuterium-depleted, ≤1 ppm (Deuterium oxide)
H2O
329886
Water-16O, 99.99 atom % 16O
H216O